Jason McCoy

2.6k total citations
30 papers, 1.8k citations indexed

About

Jason McCoy is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Jason McCoy has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Jason McCoy's work include Multiple Myeloma Research and Treatments (9 papers), Lung Cancer Research Studies (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jason McCoy is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Lung Cancer Research Studies (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jason McCoy collaborates with scholars based in United States, Italy and Greece. Jason McCoy's co-authors include John Crowley, David R. Gandara, Bart Barlogie, Howard West, Paul H. Gumerlock, Wilbur A. Franklin, Paul A. Bunn, Ana C. Xavier, Marileila Varella‐Garcia and Fred R. Hirsch and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Jason McCoy

29 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason McCoy United States	14	882	681	649	634	328	30	1.8k
M. Naveed Shaik United States	19	834 0.9×	573 0.8×	1.1k 1.6×	523 0.8×	300 0.9×	42	2.1k
Ashwin Gollerkeri United States	19	1.1k 1.2×	913 1.3×	687 1.1×	357 0.6×	710 2.2×	66	2.2k
James A. Reeves United States	17	1.7k 1.9×	536 0.8×	926 1.4×	1.4k 2.2×	276 0.8×	59	2.6k
Nushmia Z. Khokhar United States	15	898 1.0×	478 0.7×	479 0.7×	569 0.9×	95 0.3×	29	1.4k
Joanne Lager United States	17	439 0.5×	296 0.4×	563 0.9×	389 0.6×	389 1.2×	37	1.2k
M. Luisa Paccagnella United States	13	857 1.0×	439 0.6×	409 0.6×	275 0.4×	143 0.4×	22	1.7k
Christian Scheffold United States	25	1.0k 1.2×	346 0.5×	900 1.4×	1.0k 1.6×	277 0.8×	75	2.3k
John D. Bonnet United States	22	1.0k 1.1×	745 1.1×	620 1.0×	264 0.4×	149 0.5×	41	1.7k
Maud Janvier France	20	597 0.7×	918 1.3×	500 0.8×	119 0.2×	483 1.5×	48	1.6k
Álvaro Aguayo Mexico	19	506 0.6×	867 1.3×	933 1.4×	111 0.2×	501 1.5×	46	1.8k

Countries citing papers authored by Jason McCoy

Since Specialization

Citations

This map shows the geographic impact of Jason McCoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason McCoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason McCoy more than expected).

Fields of papers citing papers by Jason McCoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason McCoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason McCoy. The network helps show where Jason McCoy may publish in the future.

Co-authorship network of co-authors of Jason McCoy

This figure shows the co-authorship network connecting the top 25 collaborators of Jason McCoy. A scholar is included among the top collaborators of Jason McCoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason McCoy. Jason McCoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morel, Pierre, Alain Duhamel, Paolo G. Gobbi, et al.. (2009). International prognostic scoring system for Waldenström macroglobulinemia. Blood. 113(18). 4163–4170. 228 indexed citations

Akerley, Wallace, Jason McCoy, Paul J. Hesketh, et al.. (2007). Gemcitabine and Irinotecan for Patients with Untreated Extensive Stage Small Cell Lung Cancer: SWOG 0119. Journal of Thoracic Oncology. 2(6). 526–530. 7 indexed citations

Weng, Chunhua, et al.. (2006). Participatory design of a collaborative clinical trial protocol writing system. International Journal of Medical Informatics. 76. S245–S251. 33 indexed citations

West, Howard, Wilbur A. Franklin, Jason McCoy, et al.. (2006). Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126. Journal of Clinical Oncology. 24(12). 1807–1813. 114 indexed citations

Hesketh, Paul J., Jason McCoy, Frank Dunphy, et al.. (2006). Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group 9914. Journal of Thoracic Oncology. 1(9). 991–995. 2 indexed citations

Williamson, Stephen K., John J. Crowley, Primo N. Lara, et al.. (2005). Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003. Journal of Clinical Oncology. 23(36). 9097–9104. 103 indexed citations

Zonder, Jeffrey A., Brian G.M. Durie, Jason McCoy, et al.. (2005). High Incidence of Thrombotic Events Observed in Patients Receiving Lenalidomide (L) + Dexamethasone (D) (LD) as First-Line Therapy for Multiple Myeloma (MM) without Aspirin (ASA) Prophylaxis.. Blood. 106(11). 3455–3455. 23 indexed citations

Hirsch, Fred R., Marileila Varella‐Garcia, Jason McCoy, et al.. (2005). Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study. Journal of Clinical Oncology. 23(28). 6838–6845. 493 indexed citations

Hussein, Mohamad A., Jason McCoy, Andrzej Jakubowiak, et al.. (2005). SWOG 0204; Phase 2 Trial of Thalidomide (T) + Dexamethasone (D) Induction Followed by Tandem Autotransplant (TAT) and Prednisone (P) + T Maintenance for Multiple Myeloma (MM).. Blood. 106(11). 1169–1169. 4 indexed citations

10.

Stiff, Patrick J., Elizabeth J. Shpall, Sharon P. Wilczynski, et al.. (2004). Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study. Gynecologic Oncology. 94(1). 98–106. 11 indexed citations

11.

Durie, Brian G.M., Michael Katz, Jason McCoy, & John Crowley. (2004). Osteonecrosis of the Jaws in Myeloma: Time Dependent Correlation with Aredia® and Zometa® Use.. Blood. 104(11). 756–756. 21 indexed citations

12.

Crowley, John, et al.. (2004). Comparable Survival in Newly Diagnosed Multiple Myeloma (MM) after VAD Induction with High Dose Therapy Using Melphalan 140mg/M2 + TBI 12 Gy (MEL+TBI) Versus Standard Therapy with VBMCP and No Benefit from Interferon (IFN) Maintenance: Final Clinical Results of Intergroup Trial S9321 in the Context of IFM 90 and MRC VII Trials.. Blood. 104(11). 539–539. 36 indexed citations

13.

Le, Quynh‐Thu, Jason McCoy, Stephen K. Williamson, et al.. (2004). Phase I Study of Tirapazamine Plus Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004). Clinical Cancer Research. 10(16). 5418–5424. 31 indexed citations

14.

Fassas, Athanasios, Bart Barlogie, Susan Ward, et al.. (2003). Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience. British Journal of Haematology. 123(3). 484–489. 11 indexed citations

15.

West, Howard, Wilbur A. Franklin, Paul H. Gumerlock, et al.. (2003). O-187 ZD1839 (iressa) in advanced bronchioloalveolar carcinoma (BAC): A preliminary report of SWOG SO126. Lung Cancer. 41. S56–S56. 14 indexed citations

16.

Shaughnessy, John D., Erming Tian, Jeffrey R. Sawyer, et al.. (2002). Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization‐defined chromosome 13 deletion in multiple myeloma: early results of total therapy II. British Journal of Haematology. 120(1). 44–52. 115 indexed citations

17.

McCoy, Jason. (1995). Long-term follow-up and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels. Journal of Oral and Maxillofacial Surgery. 53(8). 975–975. 3 indexed citations

18.

McCoy, Jason. (1994). A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Journal of Oral and Maxillofacial Surgery. 52(4). 430–430. 5 indexed citations

19.

McCoy, Jason. (1988). Estimating the risks of transfusion—Associated acquired immune deficiency syndrome and human immunodeficiency virus infection. Journal of Oral and Maxillofacial Surgery. 46(4). 345–345. 1 indexed citations

20.

Riddell, A G, et al.. (1954). Studies With Dilatol, a Vasodilator Substance. Angiology. 5(4). 314–317. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact